Discovery Life Sciences
@DiscLS
Followers
1K
Following
637
Statuses
5K
We are the biospecimen and biomarker specialists™. Biospecimen solutions and expert service laboratories to accelerate precision medicine programs. https://t.co/zS2Qna93or
Huntsville, Alabama, USA
Joined July 2009
Nearly 40% of cancer cases and 44% of cancer-related deaths are linked to preventable lifestyle factors (ACS): Join us in raising awareness to reduce cancer risk and promote well-being! #NationalCancerPreventionMonth
0
0
0
Discovery’s proteomics experts will be attending @us_hupo February 23-24. Attend our three poster presentations and join an exciting course about how to market your proteomics research. Schedule a meeting today! #USHUPO2025
0
0
1
Selecting the right in vitro liver metabolism model to assess hepatotoxicity and drug metabolism is crucial in ADMET studies. Read our new blog post to learn more: #hepatocytes #ADMET #preclinical
0
0
0
Cancer impacts millions each year, and behind every diagnosis is a unique story. Together, we can raise awareness, drive action, and invest in innovations to achieve better outcomes and transform the future of cancer care. #WorldCancerDay #UnitedByUnique
0
0
0
We are proud to be recognized as a top-performing supplier on the marketplace for 2024—an honor we’ve received for multiple consecutive years. We look forward to continue to connect and explore new opportunities to support your research!
0
0
0
Today, we honor Dr. Martin Luther King Jr, a visionary relentless pursuit of racial justice, equality, and unity transformed the course of US history. His legacy inspires us to build a better and more equitable future.
0
0
0
Join Discovery on Jan 15 at 10 AM EST/4 PM CET for @OlinkProteomics's next Multiomics Coffee Break. Gain insights on combining Olink® Explore/Explore HT & LC-MS to improve proteome coverage and enhance biomarker discovery & validation. Don't miss it —
0
0
0
Warm wishes from all of us at Discovery Life Sciences. May this holiday season bring you moments of joy, gratitude, and rest as we look ahead to another year of collaboration and progress. Here’s to pushing the boundaries of discovery and achieving even greater things—together.
0
0
0
PTC Therapeutics' Kebilidi gains FDA approval as the first-ever gene therapy for direct brain administration to treat AADC deficiency—a rare, and typically fatal genetic disorder. #raredisease #genetherapy
0
0
1
Tremendous progress has been made in combating HIV/AIDS, yet critical work remains. New initiatives like PEPFAR’s new action plan close HIV-service gaps for key populations and ensure equitable access to testing, prevention, and treatment. Learn more:
0
0
0
Last chance! Discovery’s Year-End Sales Event ends soon. Save big on a wide range of products and services before December 31, 2024. Supplies are limited—act now!
0
0
0
Optimize patient selection and resolve genotyping ambiguities with Discovery’s Clinical Trial HLA Typing Services:
0
0
0
A new immunotherapy, nivolumab, combined with chemotherapy is raising Hodgkin lymphoma survival rates to 92% and reducing long-term side effects. The FDA will soon decide whether nivolumab should become the new standard of care for patients. Read more:
0
0
0
From ancient remedies to pioneering insights, Native Americans influences are woven into our everyday lives, enriching our understanding of medicine and health in ways that continue to benefit us today. #NativeAmericanHeritageMonth
0
0
0
New research from the Wellcome Sanger Institute maps drug resistance in cancers using CRISPR base editing & single-cell genomics. Researchers found 4 main categories that could guide clinical decisions and help develop better treatments. Read more: #CRISPR
0
0
0